Medical Condition News

RSS

Alzheimer's disease: $14.5 trillion burden on global economy by 2050

Study estimates that Alzheimer's disease and other dementias will cost the global economy $14.5 trillion by 2050, disproportionately impacting high-income countries. Researchers call for urgent global action to mitigate this rising economic burden.

4 Sep 2024

Ultra-processed foods significantly raise heart disease risk

Higher intake of ultra-processed foods is linked to increased risks of coronary heart disease and cardiovascular disease in U.S. adults, with certain processed foods like meats and sugary drinks posing significant dangers.

4 Sep 2024

Alirocumab reduces dangerous coronary plaque and stabilizes high-risk lesions

Intensive LDL-C lowering with alirocumab significantly reduces high-risk coronary plaque burden, transforming unstable plaques into more stable phenotypes. This lesion-level analysis underscores the enhanced efficacy compared to vessel-level approaches.

4 Sep 2024

Study reassures patients about semaglutide safety

Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons without known major mental health disorders, according to a new study led by researchers from the Perelman School of Medicine at the University of Pennsylvania published this week in JAMA Internal Medicine.

4 Sep 2024

Study shows how troriluzole can target early-stage alterations associated with Alzheimer's

In a recent development in Alzheimer's disease research, Auburn University scientists have studied a new drug, troriluzole, that can prevent brain changes leading to memory loss and cognitive decline in a mouse model of the disease.

3 Sep 2024

AI model enhances detection of immune-related adverse events in cancer patients

While immune checkpoint inhibitors (ICIs) can provide lifesaving treatment for patients with cancer, they have also been found to cause immune-related adverse events (irAEs) - side effects that can impact almost every organ in the body to varying degrees.

3 Sep 2024

PQBP3 protein found to play key role in aging and brain disorders

In a recent study published online on August 5 2024 in The EMBO Journal, researchers from Tokyo Medical and Dental University (TMDU) in Japan have uncovered a crucial piece of this puzzle by focusing on the role of a single nucleolar protein.

3 Sep 2024

Gut bacteria pathways directly linked to insomnia risk identified

Study uncovers a causal link between specific gut microbiome metabolic pathways and insomnia, highlighting potential therapeutic targets for improving sleep quality.

3 Sep 2024

Metabolic syndrome risk: The role of diet in young adults

Researchers found that young adults following a Legume-Nut diet with irregular physical activity have a higher risk of metabolic syndrome, while those on an Egg-Vegetable diet face a lower risk. Regular physical activity significantly modifies these risks.

3 Sep 2024

Major trial to test multiple drugs for progressive supranuclear palsy

A clinical trial that will test three drugs concurrently, and could include more, represents new hope for patients with progressive supranuclear palsy (PSP), an incurable neurodegenerative disorder that usually kills within seven years after symptoms start.

3 Sep 2024

Penn research uncovers key biomarker for diagnosing sarcoidosis

Sarcoidosis is a rare systemic disease that afflicts an estimated 200,000 people in the US, more often people who are Black and more women than men, particularly when it causes chronic skin disease.

3 Sep 2024

New protocol explores the combination of aerobic exercise and cognitive rehabilitation for MS patients

Researchers at Kessler Foundation have published a new clinical protocol examining the combination of aerobic exercise and cognitive rehabilitation to improve learning and memory in individuals with multiple sclerosis (MS) who have mobility disability.

3 Sep 2024

Medical Condition News

Alzheimer's disease: $14.5 trillion burden on global economy by 2050

Ultra-processed foods significantly raise heart disease risk

Alirocumab reduces dangerous coronary plaque and stabilizes high-risk lesions

Study reassures patients about semaglutide safety

Study shows how troriluzole can target early-stage alterations associated with Alzheimer's

AI model enhances detection of immune-related adverse events in cancer patients

PQBP3 protein found to play key role in aging and brain disorders

Gut bacteria pathways directly linked to insomnia risk identified

Metabolic syndrome risk: The role of diet in young adults

Major trial to test multiple drugs for progressive supranuclear palsy

Penn research uncovers key biomarker for diagnosing sarcoidosis

New protocol explores the combination of aerobic exercise and cognitive rehabilitation for MS patients

Dietary habits or gastrointestinal disease associated with the development of belching disorders

Garlic’s antioxidant and nitric oxide boosting effects may help lower blood pressure

European Society of Cardiology highlights underrecognized link between obesity and heart disease

Beer and cider significantly raise gout risk for both sexes, but men are more affected

Plant-based fats outperform dairy fats in reducing heart disease and diabetes risks

MYO1D mutation identified as a key factor in sperm defects and congenital conditions

Funding boost accelerates development of promising rheumatoid arthritis treatment

National survey reveals gaps in ADHD treatment for young adults

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News